Skip to main content

Advertisement

Fig. 5 | BMC Cancer

Fig. 5

From: The differences between gonadal and extra-gonadal malignant teratomas in both genders and the effects of chemotherapy

Fig. 5

The five-year observed survival rates with age adjustment of malignant teratomas divided by chemotherapy and supportive care groups. The observed survival rates of malignant teratomas divided by chemotherapy and supportive care groups in male and female (a, d). The observed survival rates of gonadal malignant teratomas divided by chemotherapy and supportive care groups in male and female (b, e). The observed survival rates of extragonadal malignant teratomas divided by chemotherapy and supportive care groups in male (c)

Back to article page